A Study To Assess A New Personalized Tool For Colorectal And Other Gastrointestinal Cancer Peritoneal Disease Treatment
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 19-004196
Sponsor Protocol Number: PDO-01
About this study
The purpose of this study is to genomically characterize PDOs and primary tissues from CRC and other gastrointestinal cancer peritoneal disease.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Age ≥ 18 years old.
Metastatic CRC and other gastrointestinal cancers (pancreas cancer, bile duct cancer, small bowel cancer, appendix cancer, gastroesophageal cancer, hepatocellular carcinoma) patients with synchronous or metachronous peritoneal metastasis
Patients who plan to undergo either diagnostic laparoscopy with tissue biopsy of the peritoneal metastases or cytoreductive surgery of the peritoneal metastases as part of routine clinical care
Patients willing to consent for biopsy
Exclusion Criteria:
Patients who will not have tissue biopsy from diagnostic laparoscopy or tumor resection from cytoreductive surgery as part of routine clinical care.
Women known to be pregnant.
Non-English speaking, students, prisoners.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 10/28/2026. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Rochester, Minn.
Mayo Clinic principal investigator Hao Xie, M.D., Ph.D. |
Closed for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
More information
Publications
Publications are currently not available